LEADER 05128nam 2201249z- 450 001 9910637781403321 005 20231214133206.0 010 $a3-0365-5611-7 035 $a(CKB)5470000001631723 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/94490 035 $a(EXLCZ)995470000001631723 100 $a20202212d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aTargeting the Microbiome for Disease Diagnosis and Therapy$eNew Frontiers for Personalized Medicine 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (280 p.) 311 $a3-0365-5612-5 330 $aBackground: The gut microbiota is emerging as a pivotal player in the pathogenesis of many non-communicable diseases. Thus, it has been proposed as a new diagnostic and therapeutic target.Aim and scope: This Special Issue will focus on the microbiome as a potential target of new personalized therapies or diagnostic tools.History: In recent decades, the gut microbiome has been deeply investigated, and many studies have provided new information on the role of dysbiosis in many gastrointestinal and extra-gastrointestinal diseases. Recently, in addition to its phylogenetic characterization, new information has become available regarding the function of the gut microbiota, thanks to proteomic and metabolomic analyses.Cutting-edge research: The therapeutic modulation of the gut microbiota based on different strategies, including diet modification, antibiotics, prebiotics, probiotics, and, last but not least, fecal microbiota transplantation, has been tested for the treatment of various diseases. Recently, the possible applications and modalities of gut microbiota modulation have been increasingly expanding.We have collected original clinical or pre-clinical research papers and reviews focusing on the use of the microbiome for disease diagnosis, monitoring, or therapy and suggesting new possible gut microbiota-based approaches for personalized care. 517 $aTargeting the Microbiome for Disease Diagnosis and Therapy 606 $aMedicine$2bicssc 610 $aGraves-Basedow's diseases 610 $aHashimoto's thyroiditis 610 $aautoimmunity 610 $agut microbiota 610 $airritable bowel syndrome 610 $amicrobiota 610 $amicrobiome 610 $afood components 610 $anutrients 610 $ahematopoietic stem cell transplantation 610 $afecal microbiota transplantation 610 $aaGvHD 610 $aantibiotic-resistant bacteria 610 $acystic fibrosis 610 $arabbits 610 $aintestinal dysbiosis 610 $afeces microbiome 610 $abeta-blocker 610 $ahemodialysis 610 $anext-generation sequencing 610 $apropensity score matching methods 610 $aviolin plots 610 $arandom sampling 610 $aanalytical reproducibility 610 $afecal matter transplantation 610 $adata disease subtypes 610 $apersonalized medicine 610 $amaltodextrin 610 $adip test 610 $agallstone disease 610 $a16S rDNA gene diversity 610 $ablood biochemical characteristics 610 $amesothelioma 610 $a16S RNA sequencing 610 $aspecies 610 $aprobiotics and gut disease 610 $aprobiotics and acute diverticulitis 610 $aprobiotics and diverticular disease 610 $aprobiotics mechanism of action 610 $aIgA Nephropathy 610 $arifaximin 610 $a?1KI-CD89Tg mice 610 $achildren 610 $aintermittent hypoxemia 610 $aobstructive sleep apnea 610 $atonsil 610 $aweight status 610 $aoral microbiota 610 $arheumatology diseases 610 $abiomarkers 610 $aartificial intelligence 610 $amachine learning 610 $arheumatoid arthritis 610 $aSjogren's syndrome 610 $asystemic lupus erythematosus 610 $aendometrial cancer 610 $aendometrial microbiome 610 $agut microbiome 610 $adysbiosis 610 $aestrogen metabolism 610 $aestrobolome 610 $ainflammation 610 $aantitumour treatment 610 $aprebiotics 610 $aprobiotics 610 $aschizophrenia 610 $adepression 610 $aanxiety 610 $afunctional genes 610 $athymoma 610 $agenera 610 $adriver mutation 610 $acardiovascular diseases 610 $acritically ill 610 $aintestinal permeability 610 $arecurrent cystitis 615 7$aMedicine 700 $aLaterza$b Lucrezia$4edt$01285497 702 $aLaterza$b Lucrezia$4oth 906 $aBOOK 912 $a9910637781403321 996 $aTargeting the Microbiome for Disease Diagnosis and Therapy$93019608 997 $aUNINA LEADER 01184nam0 22003011i 450 001 UON00140276 005 20231205102838.455 100 $a20020107d1928 |0itac50 ba 101 $aara 102 $aEG 105 $a|||| 1|||| 200 1 $aMabadi' al-falsafah$fA.S. Rapupert$g[trad.] Ahmad Amin 210 $aal-Qahira$cMatba'a wa'l-kitab al-misriyyah$d1928 215 $a198 p.$d19 cm 316 $aEx inv. R 7560$5IT-UONSI ARAVIIB/148 606 $aFilosofia Islamica$3UONC001878$2FI 620 $aEG$dIl Cairo$3UONL000377 686 $aARA VII B$cPAESI ARABI - FILOSOFIA E RELIGIONE - FILOSOFIA$2A 700 1$aRAPUPERT$bA. S.$3UONV084918$0671232 702 1$aAm?n$bA?mad$3UONV017331 712 $aDar al-Kutub al-Misriyya$3UONV249062$4650 790 1$aAHMAD, Amin$zAm?n, A?mad$3UONV017332 801 $aIT$bSOL$c20250523$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00140276 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI ARA VII B 148 $eSI SA 99560 7 148 Ex inv. R 7560 996 $aMabadi' al-falsafah$91278809 997 $aUNIOR